Literature DB >> 10820053

Structure-activity relationships of (1'S)-1'-acetoxychavicol acetate, a major constituent of a southeast Asian condiment plant Languas galanga, on the inhibition of tumor-promoter-induced Epstein-Barr virus activation.

A Murakami1, K Toyota, S Ohura, K Koshimizu, H Ohigashi.   

Abstract

The structure-activity relationships of (1'S)-1'-acetoxychavicol acetate (ACA), a cancer chemopreventive agent of food origin, were investigated in an inhibitory test of tumor promoter teleocidin B-4-induced Epstein-Barr virus (EBV) activation in Raji cells. Through a test of 16 derivatives, the structural factors regulating activity were found to be as follows: (1) the absolute configuration at the 1'-position does not affect activity; (2) hydrogenation of the terminal methylene group abolishes activity; (3) both the phenolic and alcoholic hydroxyl groups are compulsorily acetylated, and it is necessary that the former is oriented only at the position para to the side chain; (4) an additional acetoxyl group is allowed to locate at the ortho or meta position; and (5) substitution of the hydrogen atom at the 1'-position by a methyl group reduces activity. Upon esterase blockade in Raji cells, (1'R,S)-ACA suppressed EBV activation, the extent of which was the same as tested in the control, suggesting that ACA bearing two acetoxyl groups is an intracellular structure prerequisite for activity exhibition. The present study suggests that nucleophilic attack to the 3'-position is important and involved in the interaction of ACA with an unidentified target molecule(s) participating in the process of EBV activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10820053     DOI: 10.1021/jf990528r

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  7 in total

1.  Acaricidal potential of active components derived from Alpinia galanga rhizome oils and their derivatives against Haemaphysalis longicornis (Acari: Ixodidae).

Authors:  Min-Seung Kang; Jun-Hwan Park; Hoi-Seon Lee
Journal:  Exp Appl Acarol       Date:  2022-01-13       Impact factor: 2.132

2.  Anti-inflammatory activity of p-coumaryl alcohol-gamma-O-methyl ether is mediated through modulation of interferon-gamma production in Th cells.

Authors:  E-S Yu; H-J Min; K Lee; M-S Lee; J-W Nam; E-K Seo; J-H Hong; E-S Hwang
Journal:  Br J Pharmacol       Date:  2009-02-18       Impact factor: 8.739

3.  Effects of the tropical ginger compound,1'-acetoxychavicol acetate, against tumor promotion in K5.Stat3C transgenic mice.

Authors:  Vinita Batra; Zanobia Syed; Jennifer N Gill; Malari A Coburn; Patrick Adegboyega; John DiGiovanni; J Michael Mathis; Runhua Shi; John L Clifford; Heather E Kleiner-Hancock
Journal:  J Exp Clin Cancer Res       Date:  2012-06-15

4.  The Effects of Aqueous Extract of Alpinia Galangal on Gastric Cancer Cells (AGS) and L929 Cells in Vitro.

Authors:  Mosa-Al-Reza Hadjzadeh; Habib Ghanbari; Zakieh Keshavarzi; Jalil Tavakol-Afshari
Journal:  Iran J Cancer Prev       Date:  2014

Review 5.  A Review on the Pharmacological Activities and Phytochemicals of Alpinia officinarum (Galangal) Extracts Derived from Bioassay-Guided Fractionation and Isolation.

Authors:  Aida Maryam Basri; Hussein Taha; Norhayati Ahmad
Journal:  Pharmacogn Rev       Date:  2017 Jan-Jun

6.  1'-Acetoxychavicol acetate inhibits growth of human oral carcinoma xenograft in mice and potentiates cisplatin effect via proinflammatory microenvironment alterations.

Authors:  Lionel L A In; Norhafiza M Arshad; Halijah Ibrahim; Mohamad Nurul Azmi; Khalijah Awang; Noor Hasima Nagoor
Journal:  BMC Complement Altern Med       Date:  2012-10-09       Impact factor: 3.659

7.  Anti-proliferative, apoptotic induction, and anti-migration effects of hemi-synthetic 1'S-1'-acetoxychavicol acetate analogs on MDA-MB-231 breast cancer cells.

Authors:  Su Ki Liew; Mohamad Nurul Azmi; Lionel LA In; Khalijah Awang; Noor Hasima Nagoor
Journal:  Drug Des Devel Ther       Date:  2017-09-18       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.